Andrea Veltri
Papers
3
Total Citations
93
H-Index
2
About
Andrea Veltri is a leading urological researcher whose work centers on improving prostate cancer diagnosis and risk stratification through advanced imaging and biomarkers. Her major contributions focus on the clinical validation of multiparametric magnetic resonance imaging (mpMRI) and its integration with novel molecular tests to enhance precision in prostate cancer management. In her highly cited 2016 study (49 citations), she demonstrated that MRI/ultrasound fusion targeted biopsy significantly improves agreement between biopsy and surgical Gleason scores compared to standard untargeted biopsy, directly impacting treatment decisions. Her landmark 2015 work (42 citations) provided a critical head-to-head comparison of mpMRI, the Prostate Health Index (PHI), and PCA3, showing how these tools can better predict clinically significant prostate cancer in men eligible for active surveillance. This comparative evaluation has helped shape contemporary risk stratification protocols. Veltri’s research is notable for its direct translational impact, offering urologists evidence-based strategies to reduce overdiagnosis and overtreatment while improving detection accuracy. Her work continues to influence guidelines for prostate cancer diagnosis and active surveillance selection.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3